Clinical Trial: A Study to Evaluate the Absorption, Distribution, Metabolism, and Excretion of [14C]-MRM-3379

U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07712718) titled 'A Study to Evaluate the Absorption, Distribution, Metabolism, and Excretion of [14C]-MRM-3379' on June 26.

Brief Summary: This is a Phase 1, open label study in healthy male participants to study the Absorption, Distribution, Metabolism, and Excretion of [14C]-MRM-3379 drug following a single oral dose.

Study Start Date: May 29

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: [14C]-MRM-3379

Oral capsule administered on Day 1 only.

Recruitment Status: RECRUITING

Sponsor: Mirum Pharmaceuticals, Inc.

Published by HT Digital Content Services with permission from Health Daily Digest....